Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

THE TRUTH ABOUT: Curaleaf - Caught on Camera

‘Should never have been prescribed’: private UK cannabis clinics face call for tighter regulation

Family pushing for greater controls after inquest finds Oliver Robinson’s prescription was ‘obstacle’ to proper care

The Guardian - UK

Cannabis Stocks Up for Reversal: Pipedreams or Opportunity?

Cannabis stocks are set up to complete market reversals that relaxed federal regulations could trigger. Rescheduling isn't legalization, but it's good enough.

MarketBeat

Want to Jump on the Cannabis Stocks Rally? This Company Has Been the Top-Performing Player in 2025.

Down almost 70% from all-time highs, Curaleaf stock offers significant upside potential given its widening free cash flow margins.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

This 1 Little-Known Cannabis Stock Is Up Nearly 90% in 2025. Is It Too Late to Buy Shares?

Curaleaf stock is up close to 90% in 2025 after President Donald Trump suggested marijuana reclassification could happen within weeks.

Barchart

This Is the Top-Performing Cannabis ETF to Buy Now

With federal marijuana reform gaining traction, the AdvisorShares Pure US Cannabis ETF (MSOS) has surged over 30% in 2025 and stands out as the top-performing fund to capture the sector’s breakout momentum.

Barchart

This Red-Hot Cannabis Stock Has Nearly Doubled in 2025. Should You Buy It Here?

CURLF rides the cannabis rally with global reach and stronger cash flow, but profitability remains elusive.

Barchart

The Price Is Right: This Weed Real Estate Stock Proves Conservative Strategies Bring Returns

New Lake Capital Partners (OTC:NLCP), a real estate company focused on cannabis properties, offers an attractive investment with a 9.1% dividend yield, well above the return on 10-year government bonds.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Europe Says Thanks But We'll Do It Ourselves - Canada Leads In Raw Cannabis Exports, Not Oil

While dried flower exports have flourished, the growth of Canada's cannabis extracts, including oils and vapes, has been more erratic.

Benzinga

Ho-Ho-Holy Smokes! Record Weed Sales Drive Dispensaries To Stock Smart This Holiday Season

Flower remained the top-selling form factor, accounting for 43% of total sales, followed by vape at 28%, and edibles.

Benzinga

Curaleaf Holdings: Is This Cannabis Company A Buy Or Hold?

In this article, we analyze Curaleaf using technical indicators, focusing on key levels and potential mid-term strategies. Let's dive in.

Benzinga

Diversify Around And Find Out: Can Vegas Superstore And Florida Sales Boost This Weed Penny Stock?

Is this 40-cent cannabis stock undervalued? Zuanic & Associates dives into its growth potential and market prospects.

Benzinga

3 Cannabis Stocks to Buy Before the Next Catalyst Hits

The cannabis industry is poised for significant growth, driven by expanding legalization and potential regulatory reforms. Three stocks that analysts believe are well-positioned to benefit from upcoming catalysts are Curaleaf Holdings, Verano Holdings, and AFC Gamma.

Barchart

Can a Criminal Enterprise Commit an Unfair Labor Practice?

Does the National Labor Relations Board have jurisdiction over a medical marijuana dispensary's treatment of its employees?

Reason

1 Growth Stock Under $10 to Buy and Hold

Amidst the DEA's anticipated rescheduling of marijuana, Curaleaf Holdings emerges as a compelling growth stock under $10, buoyed by strategic expansions, regulatory tailwinds, and bullish analyst forecasts in the flourishing cannabis industry.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

3 Cannabis Stocks With More Upside Potential Than Canopy Growth

Three lesser-known cannabis companies are quietly making moves that could position them as more attractive investment opportunities than the headline-grabbing Canopy Growth.

The Independent UK

After troubled start, New York is shaking up its legal marijuana market with new competitors

New York is dramatically expanding a legal marijuana market plagued by a sluggish rollout of retail stores

Barchart

3 Cannabis Stocks That Have More Upside Potential Than Canopy Growth, According to Wall Street Analysts

CGC has nearly tripled since late August - and now these three marijuana stocks have more upside potential, according to Wall Street.

Kiplinger

Missouri's Recreational Weed Market Faces Product Shortage: This Week in Cannabis Investing

The Show Me State's recreational weed market has been red hot, but now demand is exceeding supply.

Get all your
news in one place.

100's of premium titles.
One news app.

Tribune News Service

States with legal pot consider how to protect cannabis workers

Most cannabis dispensaries are cash-only businesses, constantly at risk of being robbed. Indoor growing facilities use harsh lighting, and plants get sprayed with pesticides.

Chicago Tribune

2022 saw a wave of new unions form. Getting to the bargaining table is the next challenge

CHICAGO — As snow fell on the picket line outside a Bucktown Starbucks in November, striking unionized baristas kept warm with cups of Colectivo Coffee, which is brewed by members of the International Brotherhood of Electrical Workers, a union that also represents baristas at Chicago-based Intelligentsia Coffee.

Benzinga

EXCLUSIVE: Maryland's Marijuana Legalization Should Benefit Cannabis Operators Of All Sizes, Say These MSOs

During the November midterms, over 65% of Maryland voters chose to&n

Benzinga

Cantor Fitzgerald Lowers Price Target On Curaleaf Stock Post Q3 Earnings

Curaleaf Holdings, Inc.

Benzinga

Curaleaf Q3 Revenue Grows 7% YoY, Driven By Constant Expansion

Curaleaf Holdings, Inc.

Benzinga

What's In The Cards For These Cannabis MSOs In Q3? Analyst's Thoughts Ahead Of Earnings Season

Several cannabis multistate operators, or MSOs, are poised to report their third-quarter financials in November. Cantor Fitzgerald's analyst Pablo Zuanic weighed in with his expectations on the upcoming earnings season and took a closer look at TerrAscend Corp. (CSE: TER) (OTCQX:

The Philadelphia Inquirer

New Jersey regulators approved the first round of licenses for new recreational weed companies

New Jersey regulators approved the first round of new licenses for recreational weed companies that weren't already growing and selling medicinal cannabis.

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the National Labor Relations Board

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.